Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
COVID-19 vaccines: your questions answered (part 2)
MP3•Episoder hjem
Manage episode 323237396 series 3329558
Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
With three COVID-19 vaccines approved in the UK, the focus is now shifting towards how the vaccination programme is being rolled out This podcast picks up where we left off in our previous one, answering a new set of readers questions submitted through the PJ website and social media. Nigel Praities, executive editor, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, attempt to answer these questions using the latest available information and the help of some external experts. Thanks to Steve Griffin, associate professor in the school of medicine at the University of Leeds, Fazila Jumabhoy, lead pharmacist for Central North Leeds Primary Care Network and John Tregoning, a reader in respiratory disease at Imperial College London. This episode was produced by Geoff Marsh. LINKS Phase 3 trials Pfizer/BioNTech: https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=pfw&jwd=000020100690&jspc= Oxford/AstraZeneca: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext Information for healthcare professionals Pfizer/BioNTech: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine Oxford/AstraZeneca: https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca Summary of product characteristics Pfizer/BioNTech: https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
…
continue reading
48 episoder
MP3•Episoder hjem
Manage episode 323237396 series 3329558
Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
With three COVID-19 vaccines approved in the UK, the focus is now shifting towards how the vaccination programme is being rolled out This podcast picks up where we left off in our previous one, answering a new set of readers questions submitted through the PJ website and social media. Nigel Praities, executive editor, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, attempt to answer these questions using the latest available information and the help of some external experts. Thanks to Steve Griffin, associate professor in the school of medicine at the University of Leeds, Fazila Jumabhoy, lead pharmacist for Central North Leeds Primary Care Network and John Tregoning, a reader in respiratory disease at Imperial College London. This episode was produced by Geoff Marsh. LINKS Phase 3 trials Pfizer/BioNTech: https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=pfw&jwd=000020100690&jspc= Oxford/AstraZeneca: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext Information for healthcare professionals Pfizer/BioNTech: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine Oxford/AstraZeneca: https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca Summary of product characteristics Pfizer/BioNTech: https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
…
continue reading
48 episoder
Alle episoder
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.